Skip to content

DR. ELISE GOETSCHALCKX

Active Private limited companyfounded 2023active for 3 yearsSalviaweg 6, 2310 RijkevorselKBO/BCE: BE 1000.513.032

Lifetime

3 annual accounts with figures on one time axis
peak of €136,466 in 2024
€92,150▼ 32.5%
peak of €96,577 in 2024
€72,969▼ 24.4%
peak of €172,608 in 2025
€172,608▲ 73.2%
€0▼ 100%
Board1 name since 2023
1 director
Documentsfilings and deeds
30-04-202692 days before the deadline
2025micro format
Gross margin from €136,466 to €92,150Registered office moved within Rijkevorsel 25-03Equity from €99,639 to €172,608Debts from €22,540 to €0Cash from €108,775 to €156,733

Key points

from the 2025 annual accounts

Equity

€172,608 ▲ 73.2%
€99,6002024€173,0002025

Equity rose in 2025 from €99,639 to €172,608.

Turnover

≈ €200,000 estimated

The micro format states no turnover.

Position in the sector

100.0%

Higher solvency than 95% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as DR. ELISE GOETSCHALCKX has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for DR. ELISE GOETSCHALCKX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 29-09-2023
  • 100 sharesdeed of 03-10-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1000513032
Registered office moved within Rijkevorsel The registered office moved from OOSTMALSESTEENWEG 47 BUS 102, 2310 RIJKEVORSEL to Salviaweg 6-2310 Rijkevorsel · General meeting of 10-01-2025 · Gazette deed
First establishment Zagerijstraat 9, Kasterlee
Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 03-10-2023 · Gazette deed
All 10 events

Comparable companies

same main activity, similar in size and age
Company
DR. ELISE GOETSCHALCKX Rijkevorsel €172,608 €92,150 100.0% -
Dokter Buytaert Kobe Bornem €176,256 €91,347 55.6% -
Dr. KHS Geel €184,401 €89,782 72.4% -
Dr. Marie-Claire Van Beek Turnhout €185,857 €94,953 87.1% -
CHRISTINE VAN HAEGENBORGH Kontich €157,524 €91,331 95.2% -
Dr. Anass El Malahi Boom €166,786 €99,226 98.6% -
Dr. Goedele Truijen Nijlen €168,690 €94,371 99.4% -

These companies have the same main activity as DR. ELISE GOETSCHALCKX: general medical practice (NACE 86210). They are comparable in size and age: total assets between €158,000 and €186,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 29-09-2023Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.350.138.7642460 Kasterlee, since 01-12-2023
Financial year end
31 December
Peppol
Reachable since 02-07-2025
Company details

Annual accounts 2025

€172,608▲ 41.3%
Filing
Filed on 30-04-2026, 92 days before the end of the filing period
Financials

Insights on DR. ELISE GOETSCHALCKX

DR. ELISE GOETSCHALCKX files the micro format. That format states no turnover. The gross margin rose from €3,747 in 2023 to €92,150 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. ELISE GOETSCHALCKX

What is the company number of DR. ELISE GOETSCHALCKX?
The company number of DR. ELISE GOETSCHALCKX is 1000.513.032. The VAT number is the same number with BE in front: BE 1000.513.032.
Where is DR. ELISE GOETSCHALCKX based?
The registered office is at Salviaweg 6, 2310 Rijkevorsel.Company details
What does DR. ELISE GOETSCHALCKX do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. ELISE GOETSCHALCKX?
DR. ELISE GOETSCHALCKX is a private limited company (BV).
When was DR. ELISE GOETSCHALCKX founded?
DR. ELISE GOETSCHALCKX was founded on 29-09-2023.
Is DR. ELISE GOETSCHALCKX still active?
Yes, DR. ELISE GOETSCHALCKX is an active enterprise in the KBO register.
What is the turnover of DR. ELISE GOETSCHALCKX?
The turnover in financial year 2025 is about €200,000. This figure is estimated from the gross margin of €92,150 and 33 comparable companies (NACE 862). It probably lies between €160,000 and €260,000.Financials
Is DR. ELISE GOETSCHALCKX profitable?
In financial year 2025, DR. ELISE GOETSCHALCKX made a profit of €72,969.
Where can I find the annual accounts of DR. ELISE GOETSCHALCKX?
DR. ELISE GOETSCHALCKX filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. ELISE GOETSCHALCKX due?
DR. ELISE GOETSCHALCKX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.